Home > Insider Trading > Repros Therapeutics Inc.

Repros Therapeutics Inc. (RPRX)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
61 - 70
Next >>

Why Disney (DIS), Amedica (AMDA), Cvent (CVT), UniPixel (UNXL), and Repros Therapeutics (RPRX) Are Spiking Today

After the OPEC countries participating in the Doha meeting this weekend failed to reach a deal to limit oil production, crude prices fell heavily on Monday.

Keep Reading →

April 18th, 2016 - Market Movers News

What's the Deal With These 5 Stocks on the Move Today?

With earnings season now in full swing, the Dow and S&P 500 are each slightly in the red as investors weigh various bits of macro-economic data and different earnings reports.

Keep Reading →

April 14th, 2016 - Market Movers News

Why Repros Therapeutics Inc (RPRX) Was One Of Black Friday's Biggest Gainers

Shares of Repros Therapeutics Inc (NASDAQ:RPRX) ended up by 45.14% during today's truncated Black Friday trading session, following the Thanksgiving holiday.

Keep Reading →

November 27th, 2015 - Hedge Funds Market Movers News

RA Capital Discloses New Passive Stake in Repros Therapeutics Inc (RPRX)

RA Capital Management, managed by Peter Kolchinsky, has revealed a new position in Repros Therapeutics Inc (NASDAQ:RPRX).

Keep Reading →

March 19th, 2014 - Hedge Funds News

11 Insider Trades To Keep An Eye On

Insider buying activity has been shown to generate annual outperformance of about 7 percentage points, according to multiple empirical studies.

Keep Reading →

October 21st, 2013 - Insider Trading News

Repros Therapeutics: New Drug Development Stimulates Insider Trading

Repros Therapeutics new drug: Insider Katherine Anderson, Chief Financial Officer at Repros Therapeutics Inc (NASDAQ:RPRX), purchased 1,000 shares of common stock last week at $23.77.

Keep Reading →

October 14th, 2013 - Insider Trading News

Safeway Inc. (SWY), DaVita HealthCare Partners Inc (DVA), Repros Therapeutics Inc (RPRX): Today's Three Best Stocks

It was, yet again, another positive day for the broad-based S&P 500 (INDEXSP:.INX), which has now pushed higher in 10 of the past 11 days and, once again, sits just a fraction off of its all-time high...

Keep Reading →

September 17th, 2013 - News

Here is What Hedge Funds Think About Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS)

At the moment, there are tons of metrics shareholders can use to monitor their holdings. A couple of the most under-the-radar are hedge fund and insider trading sentiment.

Keep Reading →

September 12th, 2013 - News

Repros Therapeutics Inc (RPRX): Hedge Funds Are Bullish and Insiders Are Undecided, What Should You Do?

To many of your peers, hedge funds are viewed as bloated, outdated financial vehicles of a forgotten age.

Keep Reading →

September 4th, 2013 - News

Do Hedge Funds and Insiders Love Cerus Corporation (CERS)?

In today’s marketplace, there are a multitude of indicators market participants can use to watch stocks. Two of the most underrated are hedge fund and insider trading movement.

Keep Reading →

June 24th, 2013 - News